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Tiivistelmä - Referat – Abstract 
 
Only little data is available on seroprevalence of tick borne diseases in Finnish dogs. Worldwide these diseases, anaplasmosis 
being one of them, are relatively widely studied. In some European countries the disease has become more common than earlier 
and it has spread more towards North just in the last few years. The aim of this study was to investigate the seroprevalence of 
Anaplasma phagocytophilum –bacterium in Finnish dogs, the PCR-positivity in relation with seropositivity and the risk factors for 
exposure to a vector borne pathogen. The hypotheseis were that Anaplasma phagocytophilum is underdiagnosed in Finland, there 
are more Anaplasma phagocytophilum -infections and seropositive dogs in the southern parts of Finland and that hunting dogs are 
more susceptible for Anaplasma phagocytophilum -seropositivity compared to pet dogs. 
For material, 390 canine blood samples (serum, EDTA) were collected all around Finland. Of these samples, 50 were from hunting 
dogs. DNA was extracted from the EDTA-samples and with real-time -PCR the PCR-positive, bacteremic dogs, were spotted. 
Seropositivity was tested from the serum samples by using commercial SNAP 4Dx-test. 
The seroprevalence of anaplasmosis in Finnish dogs was 4,6% (18/390) and in hunting dogs 4,0% (2/50). Regionally in Åland 
there were more seropositive dogs than elsewhere in Finland. In Åland the seropositivity was 45% (9/20). Small dogs were more 
often seropositive than large dogs. Only two Finnish dogs were PCR-positive (2/390), meaning they had Anaplasma 
phagocytophilum -infection. These two dogs were seronegative. 
This study suggests that canine anaplasmosis is an important tick borne disease in Finnish dogs. The results show that dogs are 
commonly exposed to anaplasmosis especially in Åland islands and small dogs may be more susceptible to infection than large. It 
is unclear at this point if the prevalence of Anaplasma phagocytophilum -exposure will increase in other parts of the country due to 
the climate change and the northern spread of Ixodes ticks.  
The prevalence of actual infection is low. Because of this low number of Anaplasma phagocytophilum -positive dogs, no risk 
factors for infection could be identified in our study. Therefore, future studies with larger number of infected dogs are necessary to 
better understand the risk factors associated with Anaplasma phagocytophilum -infections in dogs and in people.  
 
Puutiaisvälitteisten tautien esiintyvyydestä suomalaisissa koirissa on vain vähän tutkimustietoa. Maailmanlaajuisesti nämä taudit, 
anaplasmoosi yhtenä niistä, ovat suhteellisen laajalti tutkittuja. Joissain Euroopan maissa tauti on yleistynyt ja se on myös levinnyt 
ylemmäs pohjoiseen Eurooppaan. Tutkimuksen tarkoituksena oli selvittää Anaplasma phagocytophilum -bakteerin esiintyvyyttä 
suomalaisissa koirissa, bakteremian suhdetta vasta-aineisiin ja arvioida altistumisen riskitekijöitä. Hypoteesejä olivat, että bakteeri 
on alidiagnosoitu Suomessa, Etelä-Suomessa on enemmän infektioita sekä vasta-ainepositiivisia ja että metsästyskoirat ovat 
alttiimpia tartunnalle kuin muut koirat. 
Materiaalina oli 390 koiran verinäytteet (kokoveri ja seerumi), joista 50 oli metsästyskoirien. Näytteitä kerättiin koko Suomesta. 
Kokoverinäytteistä eristettiin DNA, joka tutkittiin reaaliaikaisen PCR:n avulla bakteremian todentamiseksi.Vasta-ainepositiivisuus 
tutkittiin veren seeruminäytteistä kaupallisella SNAP 4Dx-testillä. 
Anaplasma phagocytophilumin vasta-aine-esiintyvyys suomalaisissa koirissa oli 4,6% (18/390) ja metsästyskoirissa 4,0% (2/50). 
Alueellisesti Ahvenanmaalla oli eniten positiivisia koiria, 45% (9/20). Pienet koirat olivat useammin vasta-ainepositiivisia kuin 
suuret. Vain kaksi koiraa oli PCR-positiivisia eli vain kahdella oli infektio (2/390). Molemmat näistä koirista olivat vasta-ainetestissä 
negatiivisia. 
Tämän tutkimuksen mukaan koiran anaplasmoosi on tärkeä puutiaisvälitteinen tauti suomalaisissa koirissa. Tulosten mukaan 
koirat altistuvat tartunnalle erityisesti Ahvenanmaalla ja pienet koirat voivat olla alttiimpia tartunnalle. Muualla maassa esiintyvyys 
oli pienempi, mutta on mahdollista, että se kasvaa tulevaisuudessa ilmaston lämpenemisen vuoksi ja puutiaisten levitessä 
pohjoisempaan.  
Varsinaisen infektion esiintyvyys oli pieni. Tästä syystä PCR-positiivisuuden ja riskitekijöiden välisiä suhteita ei voitu analysoida. 
Aihetta tulee tutkia tarkemmin ja tulevissa tutkimuksissa tulee ottaa laajemmasta joukosta koiria näytteitä, jotta saadaan enemmän 
tietoa infektioiden ja vasta-ainepositiivisuuksien suhteista sekä parempi ymmärrys Anaplasma phagocytophilum-infektioihin 
liittyvistä riskitekijöistä koiria ja myös ihmisiä ajatellen. 
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1 INTRODUCTION 
 
The incidence of Anaplasma phagocytophilum (Ap) –infections in humans and dogs has 
increased during the last decades. Ap is a bacterium that causes the tick borne disease 
anaplasmosis. The bacterium is zoonotic (Chomel 2011) and transmitted to animals by 
Ixodes ticks being active during the vegetation period (daily mean temperature being 
over 5°C) (Jaenson & Lindgren 2011).  
 
Many bacteria have been renamed during this century as molecular methods have 
progressed. Due to advanced molecular techniques, Ehrlichia phagocytophila, Ehrlichia 
equi and human granulocytic ehrlichiosis (HGE) agent were also renamed 
phylogenetically as one species, Ap (Dumler et al. 2001). 
 
The northern position of Finland and the Baltic Sea makes this country in a way 
isolated. This isolation causes a geographic impact that holds up or inhibits the 
spreading of many infectious diseases from southern Europe. But as migratory birds 
may transmit many diseases, human and pet travelling has increased, and climate is 
changing (Reed et al. 2003, Laakkonen et al. 2009), Ap is regarded as an emerging 
vector borne pathogen (Dumler et al. 2007). Finnish humans and animals are then 
susceptible to acquiring infectious diseases, even though Finnish climate and Baltic Sea 
that surrounds the country in South and West are thought to be main inhibitory 
factors of the spread of diseases (Reed et al. 2003, Laakkonen et al. 2009).  
 
In Finland the first reported Ap infection was in bovine (Tuomi 1966). World widely the 
first verified human granulocytic ehrlichiosis (anaplasmosis) infections were reported 
in the USA in 1994 (Bakken et al. 1994) and in Europe (Slovenia) few years later 
(Petrovec et al. 1997).  The first Ap-infection in any Finnish companion animal was 
reported only few years ago in a cat (Heikkilä et al. 2010). Since then Ap-infection has 
been reported in Finland in a horse (Valkjärvi et al. 2010) and two dogs (Mäkitaipale 
2011). Given the limited data available relating to this pathogen in Finland, it is 
important to get a better general understanding of the exposure and prevalence of Ap-
infection in dogs. With this knowledge it is possible to assess the risk of infection in a 
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given dog and its clinical manifestations. The prevalence of Ap in pet dogs could also 
act as a good indicator for the corresponding risks to people since dogs live mainly 
with their owners and owners spend time in the same habitat with their dogs e.g. at 
home, summer cottages, woods and nature making them susceptible for tick bites and 
Ap-infection. The American College of Veterinary Internal Medicine (ACVIM) published 
a consensus statement on ehrlichial infections in small animals (Neer et al. 2002). But 
since then new studies have been published e.g. on infections, epidemiology, 
laboratory methods and findings, sings and treatment, and Ap seems to infect dogs 
more often than before. On the other hand diagnostic methods have been developed 
which may have increased the positive results on diagnosing Ap infection suspected 
dogs leading probably to a rather relative than absolute increase. 
 
The objectives of this study were to investigate 
1) The seroprevalence of Ap in Finnish dogs;  
2) The PCR-positivity in relation with seropositivity and  
3) The risk factors for exposure to a vector borne pathogen.  
 
The hypothesis were the following  
1) Ap is underdiagnosed in Finland, since Ap is an emerging zoonotic pathogen, its 
diagnostic tools are not yet that commonly used and its infections can be subclinical 
and latent without clear sings;  
2) There are more Ap-infections and seropositive dogs in the southern parts of Finland, 
especially in Åland, since Åland is known for its large ticks population and high 
incidence of tick-borne diseases and  
3) Hunting dogs are more susceptible for Ap-seropositivity compared to pet dogs, as 
they spend more time in the nature and at tick habitats.  
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2 LITERATURE REVIEW  
 
2.1 Anaplasma phagocytophilum (Ap) 
 
Ap is in the order Rickettsiales, and in the family Ehrlichiaceae that includes members 
of the genera Ehrlichia, Anaplasma, Cowdria, Wolbachia and Neorickettsia. Ap is a 
member of the genus Anaplasma. At the same time of naming Ap, Ehrlichia platys was 
renamed as Anaplasma platys, since it was found to be more closely related to 
Anaplasma species rather than Ehrlichia (Dumler et al. 2001). 
 
Canine granulocytic anaplasmosis is a zoonotic bacterial arthropod borne disease 
caused by an obligate intracellular rickettsial organism Ap (Dumler et al. 2001, Carrade 
et al. 2009). Ap is a gram-negative cocci bacteria with size less than 1,0 μm. It does not 
have lipopolysaccharide on its surface (Lin et al. 2003) as many other gram-negative 
bacteria. 
 
2.2 Geographic distribution and seroprevalence 
 
To date two Anaplasma-species have been identified in dogs in Europe: A. platys and 
Ap. A. platys has been identified in Portugal and Italy (Santos et al. 2009, Ramos et al. 
2014) whereas Ap has been identified more widely infecting dogs in Europe e.g. in Italy 
(Solano-Gallego et al. 2006a), Spain (Solano-Gallego et al. 2006b), Austria (Kirtz et al. 
2007), Germany (Barutzki et al. 2006) and the United Kingdom (Volgina et al. 2013). In 
Northern Europe, Ap has been identified in dogs in Finland’s western neighbor Sweden 
(Egenvall et al. 2000a) and in Finland (Mäkitaipale 2011). Ap has been also identified in 
dogs in Russia (Volgina et al. 2013) which is Finland’s eastern neighbor with a long land 
border. In ticks Ap has been identified in Northern Europe in e.g. Estonia (Mäkinen et 
al. 2003), European Russia (Alekseev et al. 2001), Sweden (von Stedingk et al. 1997) 
and Norway (Jenkins et al. 2001).  Ap is thought to be endemic throughout Europe 
(Greene 2012). In Figure 1 is shown the geographic distribution of Ap in Europe. 
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Figure 1. Geographic distribution of Ap in Europe. 
 
Ap has been diagnosed in many European countries and some studies on its 
prevalence have been made. Ap prevalence and its distribution have increased in the 
last few years in many countries as can be seen in Table 1. This increase is a result of a 
mixture of many factors such as climate and habitat management change, increased 
tick populations and distribution, and prevailing social and economic conditions 
(Godfrey & Randolph 2011). Over years Ap infections have become more common and 
have spread to new niches in Europe possibly due to globalization, urbanization, global 
warming and increased travelling (Rizzoli et al. 2014). In table 1 is shown prevalence of 
Ap infections in different European countries.  
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Table 1. Prevalence of Ap infections in European countries in dogs. IFAT and SNAP 4Dx 
ELISA are serological methods. 
     
Country Number of 
dogs (n) 
Prevalence 
(%) 
Method Reference 
Albania 30 40,0 IFAT Hamel et al. 2009 
Austria 1470 56,5 IFAT Kirtz et al. 2007 
France 919 2,7 SNAP 4Dx Pantchev et al. 2009 
Germany 1124 50,1 IFAT Barutzki et al. 2006 
  111 43,2  
6,3 
IFAT 
PCR 
Jensen et al. 2007 
  5881 21,5 SNAP 4Dx Krupka et al. 2007 
  522 43,0  
5,7 
IFAT 
PCR 
Kohn et al. 2011 
  448 19,4 SNAP 4Dx Barth et al. 2012 
Hungary 1305 7,9 SNAP 4Dx Farkas et al. 2014 
 Italy 460 0,0 PCR Solano-Galleno et al. 2006a 
  5634 32,8 IFAT Torina & Caracappa 2006 
  249 38,0 IFAT Pennisi et al. 2012 
  215 15,0  
0,02 
IFAT 
PCR 
Ebani et al. 2013 
Latvia 470 11,4 SNAP 4Dx Berzina & Matise 2013 
Poland 192 1,0 PCR Skotarczak et al 2004 
Portugal 55 55,0 
0,0 
IFAT 
PCR 
Santos et al. 2009 
Romania 1146 5,5 SNAP 4Dx Mircean et al. 2012 
Russia 442 1,1 SNAP 4Dx Volgina et al. 2013 
 82 34,1 SNAP 4Dx  
Spain 466 11,5 IFAT Solano-Gallego et al. 2006b 
  1100 3,1 SNAP 4Dx Miro et al. 2013 
Switzerland 996 7,5 IFAT Pusterla et al. 1998 
Sweden 611 17,7 IFAT Egenvall et al. 2000a 
  248 20,7 IFAT Jäderlund et al. 2007 
UK 120 0,8 PCR Shaw et al. 2005 
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In conclusion, anaplasmosis is an emerging disease worldwide. However, its 
prevalence has not been widely studied in Finland. At the time of starting this project, 
there were no epidemiological studies on Ap-prevalence in Finland. That is why the 
presented study was initiated and its results became part of a recently published paper 
addressing this topic (Pérez Vera et al. 2014). An epidemiologic study about the 
exposure in dogs will provide the basis for future studies that may help understand the 
public health impact of this disease in Finland. 
 
2.3 Vector, reservoirs 
 
In Europe Ap is transmitted by Ixodes ticks (Ixodes ricinus, I. persulcatus and I. 
hexagonus) (Baumgarten et al. 1999, Ravyn et al. 1999, Strle 2004) main vector being I. 
ricinus (Strle 2004). This bacterium infects many mammals e.g. dogs and ruminants 
(Dumler et al. 2001), bovine species (Stuen 2007), horses (Bjöersdorff et al. 1990), cats 
(Bjöersdorff et al. 1999), small mammals such as rodents (Liz et al. 2000), European 
hares (Hulinska et al. 2004) and humans (Petrovec et al. 1997). Ap does not transmit 
transovarially but transstadially (Dumler et al. 2001) and it stays alive in the 
environment through its reservoir hosts, including small mammals (Carrade et al. 
2009), cervids and other wild ruminants (Stefanidesova et al. 2008). The first study 
examining the presence of Ap in wildlife reservoir host species in Finland was recently 
published by Kallio et al. (2014). The authors presented the first evidence of Ap being 
present in wild rodents (bank voles) in Finland and that 22% of bank voles were 
infected by the bacterium and acted as reservoir hosts. Also birds are possible hosts 
and may facilitate the spreading of the bacterium from one area to another 
(Bjöersdorff et al. 2001). 
 
2.4 Infection 
 
There seems to be no predisposition on which and what kind of dogs the bacterium 
infects (sex, age, breed, healthy, sick) (Egenvall et al. 1997), but elderly dogs have been 
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more often seropositive (Egenvall et al. 2000a, Kohn et al. 2011), which could be 
explained by a higher exposure to ticks and Ap throughout their life time.  
 
After tick infestation, the pathogen enters through tick’s saliva to peripheral circulation 
of the mammal host and targets vertebrate host myeloid and non-myeloid cells, mainly 
neutrophils and rarely eosinophils (Dumler et al. 2001). With its surface protein the 
bacterium binds to leucocytes surface and through endocytosis it enters the cell 
(Webster et al. 1998). The bacterium is present within intracytoplasmic vacuoles 
(endosomes) as morulae (Dumler et al. 2001). Inside the morulae it multiplies until cell 
lysis or apoptosis occurs and bacteria are released, or through exocytosis enabling it to 
infect other granulocytes (Webster et al. 1998). By inhibiting endothelial cell function, 
transmigration, neutrophil phagocytosis and binding of the neutrophil to the 
endothelial wall (Choi et al. 2003) Ap slows down leucocytes apoptosis for 
approximately 24 hours and enables itself to multiply without cell lysis by evading host 
cell defenses (Ge et al. 2005). 
 
Morulae can be first found from the blood between 4 to 14 days (median six days) 
after infection/inoculation and they circulate in the blood for only 4 to 8 days during 
the first 2 weeks after transmission (Egenvall et al. 1998). After infection and morulae 
development antibodies start to rise as a response for the infection (Carrade et al. 
2011). Antibodies against Ap develop approximately one week after infection and 
persist for 6 to 8 months. If a dog is treated for anaplasmosis with antibiotics the 
antibodies can decrease to a non-detectable level (Egenvall et al. 2000a, Kohn et al. 
2008, Carrade et al. 2011). 
 
2.5 Clinical signs and imaging findings of Ap-infection 
 
Ap infects several mammalian species and the clinical signs are mainly similar between 
species (Ravnik et al. 2009). After 1-2 weeks of incubation period the infected dog may 
show severe clinical signs or it can have a self-limiting fever and illness (Egenvall et al. 
1998). This is called the acute stage of anaplasmosis. Most dogs do not get clinically 
sick (Kohn et al. 2011).  
8 
 
 
Common clinical signs of infection are acute illness with lethargy and fever (4-14 days) 
and inappetence (Ravnik et al. 2009). Other main signs or findings associated with Ap-
infection in dogs include short bacteremia (4-14 days), lameness, anemia and 
thrombocytopenia as well as impaired immunity (Carrade et al. 2009, Woldehiwet 
2010). Lameness is a common sign in anaplasmosis and it developes because of 
secondary immune-mediated (neutrophilic) polyarthritis. Other findings are pale 
mucous membranes, tense abdomen and diarrhea/vomiting (Kohn et al. 2008, Ravnik 
et al. 2009). The infected dog can also have mildly enlarged lymph nodes, tachypnea 
and endothelial hemorrhage (petechiae, melena and epistaxis caused by 
thrombocytopenia). More rare signs are collapse, scleral injection, uveitis, mild cough, 
limb edema and PD/PU (Ravnik et al. 2009, Eberts et al. 2011). Ap can also enhance 
some immunopathies to develop such as immune-mediated thrombocytopenia and - 
anemia (Kohn et al. 2008). On the other hand previous studies have shown that dogs 
can also have Ap-infection with no clinical signs (Jensen et al. 2007, Carrade et al. 
2009, Kohn et al. 2011).  
 
In an ultrasound and x-ray an enlarged spleen can be seen as a very common finding in 
infected dogs (Kohn et al. 2008). 
 
2.6 Laboratory findings, diagnostics, persistence 
 
The main laboratory findings along with short bacteremia and thrombocytopenia are 
non-regenerative mild to moderate normocytic normochromic anemia (regenerative 
anemia is rare), lymphopenia, neutrophilia (sometimes left shift), neutropenia (or 
normal neutrophil concentration), hyperglobulinemia, hypoalbuminemia, increased 
alkaline phosphatase, mild hyperbilirubinemia, neutrophilic inflammation in synovial 
fluid. Sometimes the direct Coombs’ test/platelet-bound antibody test can be positive 
(Ravnik et al. 2009, Carrade et al. 2009, Woldehiwet 2010, Eberts et al. 2011).  
 
Ap can be detected from a direct blood smear, when morulae are seen in neutrophils. 
Direct blood smear can be considered a good diagnostic tool as morulae have been 
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found in almost 60 % of clinical cases (Kohn et al. 2008). Morulae can be seen in 
neutrophils after 4 days of infection and they persist usually 4 to 8 days. Ap may 
participate in the development of subclinical or chronic disease and has been found 
from dogs blood up to six months after inoculation (Egenvall et al. 2000b). However, 
blood samples negative for morulae do not exclude an Ap infection calling for more 
advanced laboratory procedures for confirmation. 
 
Serological tests for Ap are IFAT (immunofluorescence antibody test) and ELISA 
(enzyme-linked immunosorbent assay). These tests detect antibodies from blood 
samples. During the acute phase of the infection these tests are usually negative as 
antibody titers grow later (Eberts et al. 2011). IFAT gives antibody titers (Jensen et al. 
2007) whereas the ELISA test SNAP 4Dx is qualitative (Stillman et al. 2014). The SNAP 
4Dx test has a synthetic peptide which is derived from the immunodominant p44 
major outer surface protein of Ap and it acts as an specific antigen for antibodies in the 
serum of infected dog. It is a fast in-house test. Cross-reactions with antibodies of 
other closely related bacterial species such as A. platys (Beall et al. 2008, Diniz et al. 
2010) or E. canis (Greig and Armstrong 2006) are common and cannot be ruled out in 
this test (Diniz et al. 2010) but since neither A. platys nor E. canis are, according to 
present knowledge, endemic in Finland they are not likely to cause cross-reaction 
problems when testing Finnish dogs that have not been abroad.  
 
PCR-detection of Ap DNA is a sensitive and specific method. Samples are usually 
peripheral blood, but tissue samples, and cerebrospinal fluid can also be taken 
depending on the case. PCR can detect the bacterial DNA in early stages of infection 
(Scorpio et al. 2011). However detection by PCR is dependent on the number of 
circulating organisms, which can fluctuate. Thus some infected animals can have 
negative PCR results (Beall et al. 2008).  
 
Ap DNA has been diagnosed with PCR from several sites in different species; from 
sheep and horse blood granulocytes (Franzen et al. 2009, Stuen et al. 2008), form 
horse’s poorly vascularized connective tissue where penetration of antibodies may be 
difficult (Chang et al. 1998) and from sheep’s skin (Granquist et al. 2010). Latter sites 
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may be places where Ap might persist.  Egenvall et al. (2000b) found that Ap persisted 
in dogs blood and Franzen et al. (2009) provided evidence for persistence of the 
bacterium for up to 4 months (at least 129 days) in the blood of horses recovering 
from acute equine granulocytic anaplasmosis. In the latter study, the horses did not 
have clinical signs of chronic disease. Ap has been seen to persist in blood, but lately 
also in dogs skin. Results of a study by Berzina et al. (2014) support that Ap can persist 
in tissues as the authors took skin biopsies from lesional skin sites. Reasons for the 
lesions were unknown after pathological and other examinations, but as the dogs were 
seropositive for Ap, they examined the skin biopsies with serological and PCR tests. 
They found that Ap can persist in the skin of seropositive dogs that are otherwise 
clinically normal, but are seropositive for Ap and have chronic skin lesions. 
 
2.7 Treatment 
 
Anaplasmosis can be treated, but it may become latent and re-infect the host later on 
(Barth et al. 2012) so follow-up studies can be recommended. Ap infection is treated 
with antibiotics. Doxycycline for 30 days at a dosage of 5-10 mg/kg twice a day has 
been usually given and is the first choice treatment for anaplasmosis (Greig & 
Armstrong 2006).  
 
Doxycycline has been known to increase liver enzyme activities when treated for 
anaplasmosis, and imidocarb may be then an option for treatment with a dosage of 6 
mg/kg SC once a day. If a sick dog has some other signs, they should be also treated, 
e.g. vomiting and regurgitation with antiemetics, H+ -blockers like ranitidine and 
metoclopramide (Kohn et al. 2008). Immune compromised dogs may benefit of 
corticosteroid treatment. Kohn et al. (2008) treated in their study Ap infected dogs 
with suspected immune-mediated thrombocytopenia with prednisolone for 7 or 14 
days (dosage of 1 mg/kg PO q12h or q24h) tapering it later down after the dogs were 
clinically better. In the same study a lame dog, with reactive polyarthritis, who did not 
respond to a 6 day NSAID and doxycycline treatment, was given prednisolone at a 
dosage of 1 mg/kg PO q12h and it improved quickly. 
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2.8 Ixodes ricinus, the vector 
 
I. ricinus is the only known vector that transmits Ap from one animal to another in 
Europe (Jaenson & Lindgren 2011). The most important life limiting factor in ticks’ life 
in Norther Europe is the temperature which is required for the normal cycle of tick’s 
different life stages. The stages are egg, larva, nymph and adult. If the climate is 
optimal the tick can go through its life cycle in one summer. In Finland ticks life cycle 
takes usually three years and at cold times it overwinters. To go through every stage of 
life cycle the tick requires a blood meal. Adult females lay eggs near the place where 
they have detached from the host, so usually ticks are most commonly localized in 
their hosts’ habitats (Radolf et al. 2012).  
 
I. ricinus is widely spread in Europe and is found through Europe in almost every 
country. The tick lives in mixed forests, open pastures and moist areas with high 
humidity. Ap is transmitted to animals by ticks when the daily mean temperature is ≥ 
5°C, hence during the vegetation period when ticks are active. Vegetation period is 
approximately 170 days long in Scandinavia, from spring to autumn. Climate change 
elongates the vegetation period making spring and autumn weather more suitable for 
ticks to reproduce for a longer time. During this century climate change has increased 
tick populations due to prolonged vegetation period in Finland (Jaenson & Lindgren 
2011). Also Dautel et al. (2008) came to the conclusion that climate change affects 
seasonal tick phenology. Already ticks have been found from Northern parts of Sweden 
at latitude of 68°N (Jaenson et al. 2012) so in the future they will presumably be found 
even further north. By the end of this century ticks and their pathogens may 
encompass most of Scandinavia all the way to 70°N, except the mountain regions 
where vegetation period remains shorter. Hence the risk of being infected by a tick has 
increased in Finland and elsewhere in Northern Scandinavia (Jaenson & Lindgren 
2011). Ticks transmit Ap, so it is presumable that the bacterium will encompass Finland 
as climate change encompasses ticks towards Northern parts of Finland. In Figure 2 the 
geographic distribution of Ixodes ricinus in Europe and Western Russia is shown. 
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Figure 2. The current known distribution of I. ricinus in Europe and in Western Russia 
officially recorded by the European Center for Disease Control (ECDC) in January 2016. 
Red areas in the map mark for the distribution. 
 
 
3 MATERIAL AND METHODS 
 
3.1 Dogs 
 
Three hundred and ninety Finnish dogs were tested for infection and antibodies 
against Ap. Group 1 included 340 sick or healthy pet dogs and group 2 included 50 
healthy hunting dogs. All samples from both groups were collected between August 
and December after the tick season during the years 2010-2012. 
 
From group 1, two hundred and nineteen blood samples were collected from sick or 
healthy dogs that came to Helsinki University’s Veterinary Teaching Hospital and from 
veterinary clinics around Finland, including the Åland islands. Approximately 50 
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veterinarians/clinics were contacted via e-mail, letter or phone. The veterinarians were 
selected randomly from different randomly selected cities around the country. Contact 
information was obtained from the internet (www.google.fi and www.fonecta.fi, key 
words: eläinlääkäri, suomi, kunnaneläinlääkäri, yhteystiedot). Twenty nine 
veterinarians or veterinary clinics of the contacted clinics were willing to participate to 
the study. They received prepaid envelopes that included the following: information of 
the study, instructions on taking the samples, needed tubes (ethylenediaminetetra-
acetic acid (EDTA) and serum) and questionnaires for the owners, where this 
information was requested: dog’s name, breed, age, sex status, health status, size, 
date of collection, address/zip code and travel history outside Finland. Veterinarians 
were asked to collect the samples during one to two weeks after receiving the 
instructions, in order to avoid any patient selection, and between August and 
December, so all the samples would be collected during the same season. The country 
was divided in to 6 areas (South, East, West, Oulu, Lapland, Åland islands) as seen in 
Figure 3. In Attachment 1 is the letter and questionnaire for the clinics and owners. 
 
In addition, 121 samples for group 1 were collected in autumn 2010 and 2011 between 
August and December. They were gathered by the research group “Canine and feline 
models of human inherited disorders” led by Hannes Lohi, PhD, Professor of Veterinary 
Molecular Genetics. 
 
For group 2, fifty hunting dog blood samples were collected between August and 
December 2012. Fourteen of the hunting dog blood samples were collected at a dog 
show in August 2012. The rest of the samples were collected later, during the autumn 
and early winter at hunting competitions. The following information was requested 
from each hunting dog: name, breed, age, sex status, date of collection and home city.  
 
Samples were taken by cephalic or jugular venipuncture in sterile EDTA and sera tubes. 
Serum was separated in to a sterile tube and all samples (EDTA and sera) were stored 
at -20 °C until analysis. Approximately 100 µl from each whole blood sample were used 
to extract the DNA using a commercial kit. 
 
14 
 
Inclusion criteria for hunting dogs were that they had no clinical signs of illness and 
had not been abroad.  
 
The study protocol was approved by the Laboratory Animal Board of the Southern 
Finland Regional State Administrative Agency. 
 
3.2 Ap: serology, DNA extraction, real-time -PCR 
 
Diagnosis of seropositivity was performed through antibody detection in serum using a 
commercially available SNAP 4Dx® (ELISA) (IDEXX, Laboratories, Inc., USA) that detects 
antibodies against Ap and Ehrlichia canis, as well as C6 antibodies against Borrelia 
burgdorferi (Bb) and antigens of Dirofilaria immitis. SNAP 4Dx® was used according to 
manufacturer’s instructions. In brief, serum samples were first equilibrated at room 
temperature (18–25°C) for 30 minutes, before 3 drops of sample were pipetted into a 
new sample tube and then 4 drops of conjugate were added to the sample tube. The 
sample tube was mixed and then the entire content of the sample tube was added to 
the sample well. After color appeared in the activation circle, the activator was pushed 
down. Results were read at 8 minutes. SNAP 4Dx tests were performed by University 
Lecturer, PhD Sami Junnikkala from Helsinki University. 
 
Diagnosis of Ap-infection was performed by me under the supervision of my 
supervisor, DVM, PhD, Dipl. ACVIM & ECVIM Cristina Perez Vera, and Research 
Assistant Kirsi Aaltonen from Haartman Institute using real-time -PCR. At first, DNA 
extraction of 100 µl of EDTA blood was performed using DNeasy® Blood and Tissue Kit 
according to the manufacturer’s instructions (Non-nucleated blood protocol, QIAGEN, 
Germany) and stored at -20 °C until further analysis. Genus-specific primers were used 
to amplify DNA from the samples. For real-time-PCR the primer sets msp2con33f (5’-
GAAGATGAWGCTGATACAGTA-3’) (Oligomer Oy, Helsinki, Finland) and msp2con151r 
(5’-CAACHGCCTTAGCAAACT-3’) (Oligomer Oy, Helsinki, Finland) were used to amplify a 
fragment of Ap DNA. In each sample 5 µl of the DNA extracted from each sample was 
added to 15 µl of reaction mixture. The final reaction mixture had a volume 20 µl 
which comprised of 5 µl of the sample DNA, 1,5 µM of each primer, 0,5 µM of probe 
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msp2 con86p (6’-FAM-TTATCAGTCTGTCCAGTAACA-TAMRA) (Oligomer Oy, Helsinki, 
Finland), 10 µl of MasterMix (qPCR ToughMixTM UNG, Quanta BioSciences IncTM) and 
3,8 µl of purified water.  
 
Real-time -PCRs were ran under the following thermal cycle conditions: initial 
activation for 1 min at 95°C, followed by 50 cycles of denaturation step for 10 s at 
94°C, an annealing step for 10 s at 53°C and extension-measurement step for 8 s at 
72°C. Samples passing the threshold before Ct 40 were considered positive.  
 
 
False-positive results were avoided by using a positive control; purified PCR-clean 
water was used as a negative control to indicate any contamination of reagents and 
enzymes. The positive control was provided by Professor Olli Vapalahti’s zoonotic 
disease research group (Haartman Institute, Helsinki, Finland). Positive and negative 
controls were included in each reaction group. Filter tips were used in all stages of 
DNA extraction and real-time –PCR.  
 
3.3 Statistical analysis 
 
Summary statistics were provided for all of the study variables by status yes/no. The 
summary statistics included frequencies and percentages. The effects of 
predetermined factors (sex age-group, size-group, region, travel history and health 
status) on the prevalence of anaplasmosis were assessed with logistic regression 
models. Each factor was first analyzed separately with univariate logistic regression 
models. Each model included only one factor at hand as fixed effect. The factors shown 
to be meaningful in the univariate models (p-value <0,1) were put into a multivariable 
logistic regression model. Significant variables at the univariate analysis were then 
individually entered into a multivariable logistic regression analysis and significance 
was set at p ≤0,05. The multivariable model included the main effects of all of the 
meaningful factors from the univariate models. With the multivariable model the 
possible correlations of the factors could be taken into account. 
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In the modeling the differences between groups were quantified with odd ratios (OR) 
and their 95 % confidence intervals (CI). All the models were constructed to model the 
risk of having anaplasmosis. All of the ORs were also constructed for that probability. 
All statistical analyses were done at 4Pharma Ltd using SAS® System for Windows, 
version 9.3 (SAS Institute Inc., Cary, NC, USA). 
 
 
4 RESULTS 
 
4.1 Dogs 
 
Group 1: Each dog was placed into one of the 6 areas in Finland (South, East, West, 
Oulu, Lapland, Åland islands) depending on the zip code of its address. No zip code 
data was available on one dog; that sample was from Helsinki University’s Veterinary 
Teaching Hospital (group 1). Blood samples included 162 samples from the South (from 
10 clinics), East 25 (6 clinics), West 92 (6 clinics), Oulu 28 (2 clinics), Lapland 12 (3 
clinics) and Åland 20 (1 clinic). Travel history was available from 193 dogs, of which 27 
had travelled abroad (Sweden, Norway, Denmark, Russia, Baltic countries, Germany, 
Italy, Belgium, Spain, England, France, Poland, Slovakia, Slovenia and USA) and these 
dogs were included in the study. Group 1 included dogs of 98 different breeds. Other 
demographic information collected from the questionnaires and their statistical 
analyses are available in Tables 2 and 3. 
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Table 2. Frequency table of each factor (region, age, sex, size, travelled abroad and 
health status) with being seropositive to Ap (seropositivity yes/no) of group 1. Data is 
presented as number of dogs and percentage (%). Univariate analysis. Statistically 
significant results are highlighted in bold. Analogous data is available in Perez et al. 
2014 article. 
Factor Parameter Seropositive (n=18) 
n (%) 
Seronegative (n=322) 
n (%) 
Univariate 
p-value 
Region 
South 
East 
West 
Oulu 
Lapland 
Åland 
Missing data 
2 (1,2) 
1 (4,0) 
6 (6,5) 
0 
0 
9 (45,0) 
 
160 (98,8) 
24 (96,0) 
86 (93,5) 
28 (100,0) 
12 (100,0) 
11 (55,0) 
1 
<0,0001 
Age <2 years 5 (4,7) 102 (95,3) 0,5001 
 2-8 years 9 (4,8) 179 (95,2)  
 >8 years 4 (9,1) 40 (90,9)  
 Missing data  1  
Sex  Male Intact 4 (2,9) 133 (97,1) 0,2488 
 Male castrated 2 (12,5) 14 (87,5)  
 Female intact 6 (4,0) 145 (96,0)  
 Female spayed 2 (9,5) 19 (90,5)  
 Missing data 4 (26,7) 11 (73,3)  
Size <10 kg 8 (12,1) 58 (87,9) 0,0196 
 10-25 kg 5 (6,0) 78 (94,0)  
 >25 kg 4 (2,3) 171 (97,7)  
 Missing data 1 (6,2) 15 (93,8)  
Travelled 
abroad 
Yes 3 (14.8) 24 (85,2) 
0,4890 
 No 15 (9,0) 151 (91,0)  
 Missing data  147  
Health status Healthy 9 (3,2) 268 (96,8) - 
 Sick 6 (10,0) 54 (90,0)  
 Missing data 3  
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Table 3. Pairwise comparisons, multivariable logistic regression analysis results. 
Statistically significant results are highlighted in bold. Results for group 1. 
Comparison 
Estimate 
(OR) 
Standard 
error 
95% CI p-value 
   Lower Upper  
<10 kg vs 10-25 kg 1,943 0,713 0,478 7,902 0,352 
<10 kg vs >25 kg 6,190 0,732 1,468 26,107 0,013 
10-25 kg vs >25 kg 
<10 kg vs atleast 10 kg 
3,185 
3,167 
0,762 
0,587 
0,711 
0,997 
14,278 
10,060 
0,130 
0,051 
East vs South 3,926 1,259 0,330 46,731 0,278 
West vs South 6,826 0,840 1,308 35,624 0,023 
Åland vs South 92,149 0,916 15,191 558,991 <0,001 
West vs East 1,739 1,123 0,191 15,855 0,623 
Åland vs East 23,472 1,178 2,311 238,428 0,008 
Åland vs West 13,500 0,718 3,286 55,456 <0,001 
Åland vs rest of Finland 34,267 0,637 9,791 119,935 <0,001 
 
 
Group 2: 50 hunting dogs off which 44 dogs were from South and six from the West. 
Group 2 had nine different breeds. Most of the hunting dogs were Finnish hounds (34 
of 50), other breeds were Jämtland spitz, Finnish spitz, Labrador retriever, English 
springer spaniel, German shorthaired pointer, German hunting terrier, West Siberian 
Laika and working Jack Russel. From group 2 no statistical analysis could be done due 
to insufficient demographic information. 
 
4.2 Ap-seroprevalence 
 
Group 1: The results and seroprevalence of Ap-infection are shown in Tables 2 and 3. 
For group 1 the seroprevalence was 5,3% (18 of 340 dogs). If Åland dogs would be 
excluded from this group, the seroprevalence would be 2,2% (7/320). If travelled Ap-
seropositive Åland dogs (n=3) would be excluded from Åland dogs (n=20), the 
seroprevalence for Åland dogs would be 35,3% (6/17). 
 
Group 2: In group 2 there were 2 Ap-seropositive dogs and seroprevalence for the 
hunting dogs was 4,0% (2/50).  
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Groups 1 & 2: In the whole country there were 20 Ap-seropositive dogs: 18 dogs from 
group 1 and 2 dogs from group 2. Seroprevalence for the whole country was 5,1% 
(20/390). If Åland dogs would be excluded from the whole country result, the 
seroprevalence would be 3,0% (11/370). Of these 11 dogs none had been abroad and 7 
were clinically healthy so 1,9% (7/370) of Finnish dogs were seropositive for Ap and 
clinically healthy without ever been abroad. In Figure 3 is a map showing Ap-infection 
and seropositive areas/dogs. 
 
 
Figure 3. Finland divided in to six regions. Anaplasma-seropositives are marked as 
green circles. Anaplasma-PCR-positives are marked as yellow triangles. Groups 1 and 2. 
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4.3 Ap-infection 
 
There were two Ap real-time –PCR-positive dogs in this study, one from each group. 
Both of the PCR-positive dogs were seronegative for Ap, clinically healthy and had not 
been abroad. The other PCR-positive dog from group 1 was from Åland and the PCR-
positive hunting dog was from Southern Finland (Figure 3). Prevalence for Group 1 is 
0,3% (1/340) and Group 2 it is 2% (1/50). For the whole country the prevalence is 0,5% 
(2/390). 
 
4.4 Statistical analysis 
 
Results for statistical analysis of group 1 are shown in Tables 2 and 3. Region and size 
were the factors associated with Ap-exposure. Given that the number of infected dogs 
was so low, no statistical analyses are available for the risk factors of infection, only 
exposure. Group 2, the hunting dogs, was not included in the statistical analysis as not 
all the demographic information was available for them. 
 
 
5 DISCUSSION 
 
This is the first study investigating purely the prevalence of Ap in Finnish dogs. The 
results of this study suggest that the presence of Ap-antibodies is not uncommon in 
Finnish dogs and that the bacterium is present not only in Åland and its dogs, but also 
in other regions of Finland. The overall seroprevalence of anaplasmosis in Finland was 
5,1% (Groups 1 and 2, 20/390). For group 1 the seroprevalence was 5,3% (18/340). On 
the contrary to the study’s hypothesis, the prevalence 4,0% for hunting dogs (Group 2, 
2/50) was less than group 1’s seroprevalence 5,3%. Possible explanations might be 
group size difference (Group 1 n=340, Group 2 n=50) and that most hunting dogs were 
from South Finland but none from Åland. Also cross reactions to A. platys, E. canis, E. 
ewingii and E. chaffeensis are theoretically possible when using the SNAP 4Dx (Greig & 
Armstrong 2006) and they can affect the results. Cross reactions are also possible in 
real-time -PCR (Kohn et al. 2011). However these mentioned bacteria are not endemic 
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in Finland, so the possibility of cross reaction in SNAP 4Dx and real- time -PCR in this 
study is rather unlikely. The seropositive dogs from group 1 were from East, South, 
West Finland and Åland, and seropositives from group 2 were from South (Fig. 3). As 
all hunting dog samples were from South and West and only 50 samples were 
collected, the amount of the samples and the area where they were collected from, 
was rather small. The results may have been different with a larger group size and 
larger collecting area. On the other hand, Åland dogs in group 1 raised the prevalence 
of group 1 and if Åland dogs would have been excluded the seroprevalence would 
have been 2,8% for group 1 (9/320), versus seroprevalence 4,0% of group 2. This 
would have indicated that hunting dogs indeed may be more susceptible for Ap 
infections. 
 
Ap-seroprevalence for dogs from Åland was 45%, which is remarkably higher than 
elsewhere in Finland (group 1, 2,8%, Åland excluded). But in Åland the travel 
history/being abroad of the dogs may have affected the prevalence, since the 
proportion of seropositive dogs was 35,3% when dogs with a travel history were 
excluded from calculations. In continental Finland travel history had no effect and the 
Ap-seroprevalence remained to be 2,8% since none of the seropositive dogs in group 1 
had travelled (according to information given by the owners). These results suggest 
that Ap is endemic in Åland and the bacterium is fairly common in the islands’ dogs 
and perhaps also in people. Åland is also known to be an island that has large 
population of I. ricinus ticks that transmit zoonoses (Mäkinen et al. 2003). This may be 
compromising for dog owners also when assessing the risks of getting a tick borne 
disease like anaplasmosis. So more studies should be made, possibly one study of 
Åland dogs alone and another of continental Finland’s dogs (pet dogs vs. hunting 
dogs); this might give more information on the situation. 
 
In this study the total seroprevalence was 5,1% (groups 1 + 2). In other European 
countries Ap-seroprevalence has grown in the 21st century as Table 1 shows. In 
Germany, SNAP 4Dx-seroprevalence for Ap was 21,5% a few years ago (Krupka et al. 
2007). A more recent study by Kohn et al. (2011) revealed an IFA-seroprevalence of 
43%. On the other hand Barth et al. (2012) tested the SNAP 4Dx-seroprevalence to be 
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19,4% in Germany. The difference of the results may be partly because of the use of 
different diagnostic methods or because of the recruitment of sera from different 
regions in Germany. Also in Sweden Ap-seroprevalence has increased in the last 
decade. Egenvall et al. (2000a) reported a seroprevalence of 17,7% and Jäderlund et al. 
(2007) of 20,7%. Same kind of changes might be expected in Finland as climate is 
changing, people travel more with their dogs and spend lots of time in nature with 
their dogs (Godfrey & Randolph 2011). The current study can serve as the base for 
future studies when assessing a similar rise of Ap infections in Finnish pet and hunting 
dogs. 
 
In addition to tick bites, Ap may also be transmitted via blood transfusion (Kohn et al. 
2011). In Finland blood donor dogs are tested with SNAP 4Dx when they donate their 
blood at Helsinki University’s Veterinary Teaching Hospital. This has been the protocol 
since the year 2011 (oral information from Helsinki University Veterinary Hospital). In 
our study, no information was collected regarding possible previous blood transfusions 
in any of our dogs included. But also, given the regular tick borne disease testing, it is 
unlikely that a dog acquires anaplasmosis via blood transfusion.  
 
Blood samples for this study were collected during August to December in years 2010-
2012. Part of the samples was collected during vegetation period and the rest of them 
after it in order to get samples from infected dogs after tick infestation. The results of 
this study might have been different if the samples had been collected at a different 
time of the year.  Ap has been found to cause persistent infection in dogs (Egenvall et 
al. 2000b, Franzen et al. 2009, Berzina et al. 2014). For this reason collecting the blood 
samples again the following winter time might have given us a better picture on the 
possibility of the persistence of Ap-infections in dogs in Finland. This possibility that 
some dogs would have become seronegative, and that some seronegative would have 
become seropositive in the winter, cannot be ruled out in our study, since no follow-up 
could be done. Also, no information was collected from the owners whether their dogs 
had been bitten by ticks or whether they received ectoparasite prevention. This may 
have an effect to the possibility of becoming infected by tick borne disease.  
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For this study it was not possible to collect follow-up information of those 2 real-time -
PCR-positive dogs. Both PCR-positive dogs were clinically healthy and had not been 
abroad, but due to lack of follow-up, it is not known if they developed clinical signs or 
antibodies, and how long they produced antibodies if they did. A tick infects a dog 
within hours after infestation and anchoring (Scorpio et al. 2011), and a dog produces 
antibodies 8-30 days after infection (Egenvall et al. 1998, Scorpio et al. 2011). Serologic 
studies show that dogs that were experimentally infected by Ap produced antibodies 
up to 4 months after infection (Egenvall et al. 2000b) and dogs that were naturally 
infected produced antibodies up to 12 months after infection (Egenvall et al. 1997). 
Seronegative results were diagnosed 22-36 months after Ap-infection (Eberts et al. 
2011) so follow-up studies (SNAP 4Dx and real-time -PCR) would have given a better 
picture of the infection and its progress in this study.  
 
Previously it has been suggested that subclinical diseases and silent elimination may be 
common, since Ap-seropositive healthy dogs have been reported (Carrade et al. 2009, 
Kohn et al. 2011). In this study the two PCR-positive dogs were Ap-seronegative. 
Previously Kohn et al. (2011) found out that 26,7% of PCR-positive dogs were 
seronegative (IFA). These dogs may have had an acute infection or the infection was 
subclinical. In the future studies follow-up samples of dogs and their clinical status 
should be made in order to get knowledge on how much the infection persists and 
what kind of diagnostic tests vets should do and how often to take them in the field to 
catch tick borne diseases.  
 
Univariate analysis of frequencies on each factor (region, age, sex, size, travelled 
abroad and health status) is shown in Table 2. Multivariable logistic regression analysis 
is shown in Table 3. Of the information that was asked from the owners and gathered 
from the dogs, two factors, region and size, were statistically significant in this analysis 
(Group 1). In group 1 anaplasmosis was significantly more common in Åland than in 
East, South, West and rest of Finland. In West there were significantly more 
seropositive dogs than in South. Small dogs (less than 10 kg) were more often 
seropositive than large dogs (over 25 kg). Statistical analysis on group 2 could not be 
done, so groups are incomparable to each other at this stage. 
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There was no statistical significance on the travel history, health status or sex, but for 
region and size. The results of the regional differences suggest that pet owners should 
carefully consider the increased risk of contact with infected ticks when living or 
travelling in Åland should use ectoparasitic treatments for exposed dogs during the 
vegetative season. To the authors knowledge no body size predisposition has been 
shown in previous studies. In some studies it has been suggested that older dogs have 
been more often seropositive than younger (Egenvall et al. 2000a, Kohn et al. 2011) 
but size has not been earlier acknowledged to have an effect of becoming infected. 
Small dogs may be susceptible to tick infestation as they may be closer to ticks habitat 
when going out with their owners as ticks live in forests, open pastures and grass areas 
(Jaenson & Lindgren 2011). 
 
As seen in this study a dog can be Ap-seropositive or real-time –PCR-positive (have an 
acute infection) without any clinical signs and without being abroad. This statistically 
insignificant finding in this study seems still to be in line with other studies that 
suggest/say that a dog can have Ap infection without any clinical signs (Jensen et al. 
2007, Carrade et al. 2009, Kohn et al. 2011). However, some studies have reported 
that Ap infection can persist and cause chronic health problems (Egenvall et al. 2000b, 
Berzina et al. 2014). If the infection persists in dogs, signs may fluctuate causing some 
difficulties for the clinicians to establish a diagnosis. This leads to the demand for 
performing follow-up examinations if dogs are presented in endemic areas with 
fluctuating clinical signs. 
 
As a result of this study it is advisable that future studies collect information from the 
owners about prophylactic ectoparasite treatments and about the burden of tick 
infestation noticed during the vegetation period. This way it will be possible to 
evaluate how heavily the dogs really have been exposed to ticks and which dogs are at 
higher risk of getting anaplasmosis. On the other hand, it has been previously studied 
that dogs that were treated against tick infestations were as seropositive as untreated 
dogs, regardless of ectoparasitic treatments. Also in the same study the researchers 
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noticed that dogs having been infested by ticks were as seropositive as dogs which 
according to their owners did not   have ticks (Kohn et al. 2011).   
 
Ap is an emerging pathogen and it should be noticed when travelling to tick rich areas 
or treating a patient with anaplasmosis-type clinical signs. Finnish people like to walk 
in the woods and nature and go to their summer cottages. Thousands of Finnish citizen 
hunt (approximately 300 000 have a license to hunt) and own hunting dogs. This leads 
to a situation where dogs and their owners have an increased risk of getting bitten by 
ticks and acquiring tick borne infections. Since dogs live in close proximity of people 
they can also transmit ticks to humans. Therefore it is important to intensify studies 
about zoonotic tick borne diseases in Finnish dogs.  
 
 
6 CONCLUSIONS AND CLINICAL RELEVANCE 
 
This study suggests that canine anaplasmosis has the potential to become an 
important tick borne disease in Finnish dogs. The results show that dogs are commonly 
exposed to this tick borne disease especially in Åland islands, and this suggests that 
people in Åland are also at an increased risk to Ap infection. It is unclear at this point if 
the prevalence of Ap-exposure will increase in other parts of the country. However, 
given the climatic change and the northern spread of Ixodes ticks it must be considered 
to be likely or even inevitable. 
 
Even though Finnish dogs are exposed to Ap, this study showed that the prevalence of 
the actual infection seems to be rather low. Because of this low number of Ap-positive 
dogs in real-time -PCR, no risk factors for infection could be identified in our study. 
Therefore, future studies with larger number of infected dogs and bigger groups are 
necessary to better understand the risk factors associated with Ap-infections in dogs 
and in people. 
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Attachment 1 
 
      HELSINGIN YLIOPISTO 
Tarvitsemme apuasi!!! 
Tutkimusaihe: Niveljalkaisvälitteiset taudit suomalaisilla koirilla 
 
Mikä on tutkimuksen tarkoitus? 
 
Tutkimuksen tarkoituksena on selvittää koirien niveljalkaisvälitteisten tautien 
esiintyvyyttä Suomessa. Keräämme verinäytteitä (EDTA ja seerumi) tällä hetkellä 
koirilta ympäri Suomen. 
 
Projekti: 
 
Testataan eri puolilta Suomea olevia koiria puutiaisvälitteisten tautien varalta 
(serologia ja PCR). Koirat voivat olla sairaita tai terveitä ja matkustaneita tai ei-
matkustaneita. Näytteiden keruu tapahtuu syys-joulukuussa 2012. Lähetämme 
tutkimukseen osallistuville klinikoille tarvittavat putket sekä vastauskuoren 
takaisinlähetystä varten. Tutkimukseen osallistuvista koirista tarvitsemme seuraavat 
tiedot: 
 
a. Signalmentti (ikä, rotu, sukupuoli) 
b. Sirunumero/tatuointi ja kotikaupunki 
c. Näytteenottopäivämäärä 
d. Sairas vai terve 
e. Matkustanut vai ei-matkustanut 
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Mitä puutiaisvälitteisiä tauteja tutkimme? 
Testaamme Snap-testillä A. phagocytophilumin, E. canisin ja B. burgdorferin 
vasta-aineita. Lisäksi tutkimme PCR:n avulla Bartonellaa ja A. phagocytophilumia 
sekä puutiaisaivokuumeviruksen (TBEV) serologiaa. 
 
Mitä putkia tarvitsemme?  
EDTA- ja seerumiputket. Olkaa hyvä, ja pitäkää näytteet (EDTA, eroteltu seerumi) 
jääkaapissa (tai pakastimessa), kunnes voitte lähettää ne meille. Lähetyksen 
tultua pakastamme näytteet ja säilytämme ne tulevia testauksia varten.  
 
OHJEET 
1. Kerätkää 1 EDTA- ja 1 seeruminäyte kustakin klinikallanne käyneestä 
koirasta yhden-kahden viikon aikana syys-joulukuussa. Pyydämme, että 
lähetätte seeruminäytteen sentrifugoituna ja eroteltuna. 
 
2. Lähetyskuoret ovat valmiiksi maksettuja, joten postikuluja tutkimukseen 
osallistumisesta ei tule. Jos tarvitsette enemmän kirjekuoria, lähetämme niitä 
pyynnöstä lisää.  
 
3. Neuloja emme valitettavasti pysty lähettämään. Jos tarvitsette niitä, ottakaa 
meihin yhteyttä. 
 
4. Ilmoittakaa kunkin putken kanssa koiran nimi ja näytteenottopäivämäärä. 
 
Jokainen näyte on tärkeä meille, ja toivomme saavamme niitä mahdollisimman 
paljon. Olkaa hyvä ja ottakaa yhteyttä, mikäli teille tulee kysymyksiä mieleen! 
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** Periaatteessa potilaskohtaisia testien tuloksia ei lähetetä. Jos eläinlääkäri tai 
omistaja haluaa tulokset, ottakaa meihin yhteyttä, niin lähetämme ne postitse tai 
sähköpostitse. 
 
Kiitos jo etukäteen yhteistyöstänne! 
 
Osoitteemme postittamista varten: 
 
Koiratutkimus/Perez  
Kliinisen hevos- ja pieneläinlääketieteen osasto 
Tunnus 5019843 
info H9013 
00003 VASTAUSLÄHETYS 
 
Lisätiedot ja yhteydenotot: Dipl. ACVIM Cristina Perez (englanniksi), eläinlääkäri ja 
sisätautien diplomaatti, cristina.perezvera@helsinki.fi, tai FM, ELK Suvi Kapiainen, 
eläinlääketieteen opiskelija. suvi.kapiainen@helsinki.fi. puh: 040-7521678. 
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Täytä tämä lomake kullekin koiralle 
 
1. Nimi, sukupuoli:  
 
2. Rotu :  
 
3. Ikä :  
     tunniste (siru, tatuointi): 
 
4. Sairas tai terve?:  
 
 
5. Koiran asuinkunta?:  
 
6. Keräyspäivä:  
 
7. Yhteystiedot (eläinlääkäri): 
 
8. Haluatteko saada tulokset? 
 
9. Matkailuhistoria (kesämökki, ulkomaille jne? Minne (kunta, maa)?) 
 
